Institutional Ownership Phathom Pharmaceuticals, Inc. (PHAT)
This table provides information about the institutional ownership of Phathom Pharmaceuticals, Inc. (PHAT). We have compiled data on the 158 institutions that hold shares in the stock, with a total of 68.6 Million shares, which have been reported (via 13F filing form) to have a value of $380 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
10,109,279
shares
|
$57.3 Million
4.92% of portfolio
|
Q2 2023
Added 20.25%
|
|
|
Medicxi Ventures Management (Jersey) LTD
|
Jan 23, 2025 Q4 2024 |
7,464,572
shares
|
$42.3 Million
13.31% of portfolio
|
Q1 2024
Added 98.48%
|
|
|
Jennison Associates LLC
|
Jan 24, 2025 Q4 2024 |
7,062,507
shares
|
$40 Million
0.04% of portfolio
|
Q4 2024
Added 20.39%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
3,671,386
shares
|
$20.8 Million
0.01% of portfolio
|
Q4 2024
Reduced 10.38%
|
|
|
Carlyle Group Inc.
Washington, DC |
Feb 13, 2025 Q4 2024 |
3,496,808
shares
|
$19.8 Million
28.4% of portfolio
|
Q2 2023
Added 19.14%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,926,373
shares
|
$16.6 Million
0.0% of portfolio
|
Q2 2024
Added 6.59%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,779,561
shares
|
$15.8 Million
0.0% of portfolio
|
Q4 2024
Added 3.09%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
2,527,054
shares
|
$14.3 Million
0.04% of portfolio
|
Q4 2024
Reduced 2.1%
|
|
|
Checkpoint Capital L.P.
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,274,157
shares
|
$12.9 Million
9.4% of portfolio
|
Q4 2024
Added 51.18%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
1,960,169
shares
|
$11.1 Million
1.14% of portfolio
|
Q4 2023
Added 53.55%
|
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
1,558,928
shares
|
$8.84 Million
0.06% of portfolio
|
Q4 2024
Added 531.29%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
1,435,106
shares
|
$8.14 Million
5.34% of portfolio
|
Q1 2022
Added 19.28%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
1,390,100
shares
|
$7.88 Million
1.28% of portfolio
|
Q4 2024
Reduced 22.96%
|
|
|
Catalys Pacific, LLC
Tokyo, M0 |
Feb 14, 2025 Q4 2024 |
1,167,114
shares
|
$6.62 Million
8.18% of portfolio
|
Q4 2024
Added 3.97%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Feb 05, 2025 Q4 2024 |
1,102,805
shares
|
$6.25 Million
0.08% of portfolio
|
Q4 2024
Reduced 2.07%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,039,936
shares
|
$5.9 Million
0.0% of portfolio
|
Q4 2024
Added 12.7%
|
|
|
683 Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,025,000
shares
|
$5.81 Million
0.6% of portfolio
|
Q4 2024
Added 1.49%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,018,495
shares
|
$5.77 Million
0.0% of portfolio
|
Q4 2024
Added 18.03%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,001,692
shares
|
$5.68 Million
0.06% of portfolio
|
Q4 2024
Reduced 61.08%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
989,927
shares
|
$5.61 Million
7.98% of portfolio
|
Q4 2024
Added 13.79%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
966,400
shares
|
$5.48 Million
0.0% of portfolio
|
Q4 2024
Added 119.89%
|
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
850,000
shares
|
$4.82 Million
4.88% of portfolio
|
Q2 2023
New holding
|
|
|
Decheng Capital LLC
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
694,254
shares
|
$3.94 Million
1.21% of portfolio
|
Q4 2024
Reduced 44.46%
|
|
|
Simplify Asset Management Inc.
New York, NY |
Feb 11, 2025 Q4 2024 |
581,935
shares
|
$3.3 Million
0.27% of portfolio
|
Q4 2024
Added 11.5%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
500,000
shares
|
$2.84 Million
0.3% of portfolio
|
Q4 2024
New holding
|